Plenary Lecture
Functional Changes in Human Mast Cells by Infectious
Diseases; Impact on the Control of Allergic Diseases
Professor Nobuyuki Fukuishi
Department of Pharmacology
Faculty of Pharmaceutical Sciences
Tokushima Bunri University
180 Nishihama-bouji, Yamashiro-cho
Tokushima, Tokushima 770-8514, Japan
E-mail:
nobuf@ph.bunri-u.ac.jp
Abstract:
Mast cells have long been
acknowledged as the major effector
cells of allergic reactions
because they possess the
high-affinity IgE receptor (Fc?RI),
which mediates the release of many
inflammatory mediators such as
histamine, leukotriene and
prostaglandin when crosslinked by
antigens. Whereas, mast cells are
located at the host-environment
interface, including the skin,
respiratory system, and
gastrointestinal tract. Recently,
it has been revealed that mast
cells share many features with
primary effector cells that belong
to the innate immune system. As
well, some investigators have
demonstrated that mast
cell-deficient W/Wv mice display
increased mortality compared with
wild-type mice using a model of
acute septic peritonitis induced
by cecal ligation and perforation
(CLP) and that the lethal effects
of CLP are prevented by the
adoptive transfer of bone
marrow-derived mast cells into the
peritoneal cavity. Indicating that
mast cells are involved in one of
the principal members of the
innate immune system. However, the
changes in the behavior of mast
cells following infectious
diseases remain unclear. We
investigated the effects of
infection on the expression of
surface receptors and uptake of
microbes by mast cells, using
bacterial components, and studied
the change in cytokine production
in mast cells after bacterial
uptake.
The change of mRNA expression for
Fc?RI was studied using RT-PCR and
real-time PCR. The changes of
surface expression of Fc?RI were
examined using flow cytometry, and
degranulation mediated by Fc?RI
aggregation was determined by ?-Hexosaminidase
release assay.
Treatment of lipoteichoic acid (LTA)
decreased the expression of Fc?RI?
mRNA on human mast cells.
Peptidoglycan (PGN) up-regulated
Fc?RI? mRNA, but down-regulated
that of Fc?RI??, an amplifier of
the surface expression of Fc?RI?.
Both LTA and PGN diminished
surface expression of Fc?RI on
mast cells detectable by flow
cytometry. As well, they also
reduced mast cells degranulation
mediated by the treatment of
antigen-specific IgE. Complement
receptor 3, which is closely
related to phagocytose bacteria by
mast cells, expression was
augmented by LTA but not by PGN or
3CpG-oligodeoxynucleotide. LTA
also enhanced the uptake of
opsonized bacteria. After
bacterial internalization, mast
cells augmented the production of
pre-inflammatory cytokines, while
Th1 and Th2 cytokine production
showed no change.
These results indicate that
bacterial infections direct human
mast cells function towards innate
immunity and away from allergic
reaction. Applying current
knowledge, bacterial components
especially TLR2 ligands give new
impetus to anti-allergic drug
development.
|